Physiology, Pathophysiology and Clinical Relevance of D‐Amino Acids Dynamics: From Neurochemistry to Pharmacotherapy

M. Verónica Donoso,Vicente Catalán‐Salas,Raúl Pulgar‐Sepúlveda,Jaime Eugenín,J. Pablo Huidobro‐Toro
DOI: https://doi.org/10.1002/tcr.202400013
IF: 6.935
2024-09-26
The Chemical Record
Abstract:Neurons, glia or endocrine glands isomerize L‐amino acids (L‐AAs) to D‐AAs counterparts. D‐AAs play a signaling role distinct from L‐AAs which participate in protein synthesis and metabolism. D‐AAs are involved in the pathogenesis of brain and other diseases. In addition, aging human proteins from the eye crystallin, bones or teeth isomerize, exclusively L‐aspartic acid residues to D‐aspartic acid via a procedure which occurs in selective aspartic acid residue following a distinct isomerization pattern. Over three decades ago, two independent groups of investigators identified free D‐aspartic and later D‐serine in specific brain nuclei and endocrine glands. This finding revealed a novel, non‐proteinogenic role of these molecules. Moreover, the finding that aged proteins from the human eye crystallin, teeth, bone, blood vessels or the brain incorporate D‐aspartic acids to specific primary protein sequences fostered the hypothesis that aging might be related to D‐amino acid isomerization of body proteins. The experimental confirmation that schizophrenia and neurodegenerative diseases modify plasma free D‐amino acids or tissue levelsnurtured the opportunity of using D‐amino acids as therapeutic agents for several disease treatments, a strategy that prompted the successful current application of D‐amino acids to human medicine.
chemistry, multidisciplinary
What problem does this paper attempt to address?